fda compounding restrictions bpc-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank FDA Panel Votes to Recommend

FDA Panel Votes to Recommend BPC 157 for Pharmacy Compounding HealingMaps Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Regulatory Updates on Compounded Peptides New Drug Loft and VLS Pharmacy Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest

SKU: 51266057443 · From meijijudolehavre.com